Insulet | PODD - Net Income

Stock Price
251.24
Daily Change
0.02 0.01%
Monthly
-11.38%
Yearly
-11.75%
Q1 Forecast
247.93

Insulet reported $87.6M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Abbott USD 1.78B 132M Dec/2025
Align Technology USD 56.75M 67.86M Sep/2025
AtriCure USD -267K 5.92M Sep/2025
Avanos Medical USD -1.4M 75.4M Sep/2025
Baxter International USD -46M 137M Sep/2025
Becton, Dickinson and Co. USD 493M 81M Sep/2025
Boston Scientific USD 755M 42M Sep/2025
Cardinal Health USD 450M 211M Sep/2025
Cooper Companies USD 84.6M 13.7M Sep/2025
Dexcom USD 179.8M 74.4M Jun/2025
Edwards Lifesciences USD 291.1M 42.1M Sep/2025
Eli Lilly USD 5.58B 78M Sep/2025
Globus Medical USD 118.97M 83.88M Sep/2025
ICU Medical USD -3.4M 38.73M Sep/2025
Insulet USD 87.6M 65.1M Sep/2025
Integra LifeSciences USD -5.4M 478.67M Sep/2025
J&J USD 5.12B 36M Dec/2025
Masimo USD -100.4M 151.7M Sep/2025
Medtronic USD 1.37B 334M Sep/2025
Merit Medical Systems USD 27.76M 4.83M Sep/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
Solventum Corp USD 1.27B 1.18B Sep/2025
Stryker USD 849M 10M Dec/2025
Tandem Diabetes Care USD -21.16M 31.24M Sep/2025
Teleflex USD -408.89M 531.47M Sep/2025
West Pharmaceutical Services USD 140M 8.2M Sep/2025
Zimmer Biomet Holdings USD 230.9M 78.1M Sep/2025